Yıl 2015,
Cilt: 17 Sayı: 3, 124 - 125, 01.12.2015
Öz
Translocation carcinoma is a recently described tumour which was replaced in the latest WHOclassification. Translocation carcinoma comprises about 1/3 of pediatric renal tumours. In thiscase report, we aimed to discuss translocation carcinoma as an important differantial diagnosisin pediatric renal tumours
Anahtar Kelimeler
Kaynakça
- Eble JN, Togashi K, Pisani P. Renal carcinomas associated with Xp11.2 translocations / TFE3 gene fusions. Ed: John N. Eble, Guido Sauter, Jonathan I. Epstein, Isabell A. Sesterhenn Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press Lyon, pp: 37-38, 2004
- Gregory T. MacLennan, Liang Cheng, Translocation Carcinoma. Ed: David G. Bostwick, Liang Cheng, Urologic Surgical Pathology, pp:101, 2008
- Robert O Petersen, Isabell A Sesterhenn, Charles J Davis, Urologic pathology. 3rd ed. Lippincott: Williams and Wilkins,pp: 64, 2008
- Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A. Renal cell carcinoma associated with transcription factor E3 expression characteristics, and prognosis. .Am J Clin Pathol. 137(5):761- 8, 2012
- Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol. 27(1):113-27, 2014 6.
- Fall B, Sarr A, Sow Y, Diao B Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement. Afr J Paediatr Surg. ;8(3):317-9. 2011
- Zhou AG, Owens CL, Cosar EF, Jiang Z. Arch Pathol Lab Med. 137(7):887-93, 2013
- Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol.126(3):349- 64, 2006
- Perlman EJ. Pediatric Renal Cell Carcinoma. Surg Pathol Clin. 3(3):641-651, 2010
- Zhong M, Weisman P, Zhu B, Brassesco M, Yang Y, Linehan WM, Merino MJ, Zhang D, Rohan S, Cai D, Yang X.; Xp11.2 Translocation Renal Cell Carcinoma With PSF-TFE3 Rearrangement 22(2), pp: 107–111, 2013
- Rajen Goyal, Elizabeth Gersbach, Ximing J. Yang, and Stephen M. Rohan Differential Diagnosis of Renal Tumors With Clear Cytoplasm: Clinical Relevance of Renal Tumor Subclassification in the Era of Targeted Therapies and Personalized Medicine. Archives of Pathology & Laboratory Medicine,(37) 4, pp: 467-480, 2013
Yıl 2015,
Cilt: 17 Sayı: 3, 124 - 125, 01.12.2015
Öz
Translokasyon karsinomu, son WHO sınıflamasında yer alan yeni tanımlanmış bir tümördür.Pediatrik böbrek tümörlerinde 1/3 oranında görülür. Bu vaka sunumunda; pediatrik böbrektümörlerinde akılda tutulması gereken bir ayırıcı tanı olan translokasyon karsinomununtartışılması amaçlanmıştır
Anahtar Kelimeler
Kaynakça
- Eble JN, Togashi K, Pisani P. Renal carcinomas associated with Xp11.2 translocations / TFE3 gene fusions. Ed: John N. Eble, Guido Sauter, Jonathan I. Epstein, Isabell A. Sesterhenn Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press Lyon, pp: 37-38, 2004
- Gregory T. MacLennan, Liang Cheng, Translocation Carcinoma. Ed: David G. Bostwick, Liang Cheng, Urologic Surgical Pathology, pp:101, 2008
- Robert O Petersen, Isabell A Sesterhenn, Charles J Davis, Urologic pathology. 3rd ed. Lippincott: Williams and Wilkins,pp: 64, 2008
- Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A. Renal cell carcinoma associated with transcription factor E3 expression characteristics, and prognosis. .Am J Clin Pathol. 137(5):761- 8, 2012
- Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol. 27(1):113-27, 2014 6.
- Fall B, Sarr A, Sow Y, Diao B Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement. Afr J Paediatr Surg. ;8(3):317-9. 2011
- Zhou AG, Owens CL, Cosar EF, Jiang Z. Arch Pathol Lab Med. 137(7):887-93, 2013
- Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol.126(3):349- 64, 2006
- Perlman EJ. Pediatric Renal Cell Carcinoma. Surg Pathol Clin. 3(3):641-651, 2010
- Zhong M, Weisman P, Zhu B, Brassesco M, Yang Y, Linehan WM, Merino MJ, Zhang D, Rohan S, Cai D, Yang X.; Xp11.2 Translocation Renal Cell Carcinoma With PSF-TFE3 Rearrangement 22(2), pp: 107–111, 2013
- Rajen Goyal, Elizabeth Gersbach, Ximing J. Yang, and Stephen M. Rohan Differential Diagnosis of Renal Tumors With Clear Cytoplasm: Clinical Relevance of Renal Tumor Subclassification in the Era of Targeted Therapies and Personalized Medicine. Archives of Pathology & Laboratory Medicine,(37) 4, pp: 467-480, 2013
Toplam 11 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Case Report |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Aralık 2015 |
| Yayımlandığı Sayı | Yıl 2015 Cilt: 17 Sayı: 3 |
Kaynak Göster
Düzce Tıp Fakültesi Dergisi Creative Commons Atıf-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.